Home300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Previous close
¥13.83
Day range
¥13.85 - ¥14.10
Year range
¥12.93 - ¥23.45
Market cap
15.59B CNY
Avg Volume
14.64M
P/E ratio
103.28
Dividend yield
2.72%
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 645.20M | 42.85% |
Operating expense | 424.14M | 38.76% |
Net income | 22.43M | -58.51% |
Net profit margin | 3.48 | -70.93% |
Earnings per share | — | — |
EBITDA | 127.47M | 2.48% |
Effective tax rate | 17.00% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 219.94M | -77.94% |
Total assets | 14.25B | -5.10% |
Total liabilities | 4.57B | -15.33% |
Total equity | 9.68B | — |
Shares outstanding | 1.12B | — |
Price to book | 1.60 | — |
Return on assets | 0.86% | — |
Return on capital | 1.07% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 22.43M | -58.51% |
Cash from operations | -46.30M | 39.22% |
Cash from investing | -65.23M | 82.73% |
Cash from financing | -98.94M | -180.59% |
Net change in cash | -210.53M | 36.40% |
Free cash flow | -2.72B | -245.41% |
About
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Founded
Sep 8, 1992
Website
Employees
1,913
